Hasnyálmirigyrák: vizsgálatok itt: Ausztria
16 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleStudy of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
- Where
- Salzburg
- Életkor
- 18 év and over
- People
- 670 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT07621718 - 2. fázisNot yet taking people in Ausztria[⁶⁸Ga]Ga-HKG301(FAP-2286) PET/CT in pancreatic and breast malignancies
- Where
- Salzburg
- Életkor
- 18 év and over
- People
- 60
- Run by
- Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH
See details and how to join2026-526498-40-00 · EU 2026-526498-40-00 - 2/3. fázisTaking peopleZanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Where
- Graz, Salzburg, Vienna
- Életkor
- 18 év and over
- People
- 440 worldwide
- Run by
- Exelixis
See details and how to joinNCT06943755 · EU 2025-521043-20-00 - 3. fázisTaking peopleA Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Where
- Graz, Innsbruck, Linz, Salzburg
- Életkor
- 18 év and over
- People
- 588 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07522073 - 3. fázisNot yet taking people in AusztriaPhase 3 Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC 6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma
- Where
- Innsbruck, Salzburg, Vienna
- Életkor
- 18 év and over
- People
- 233 worldwide
- Run by
- Revolution Medicines Inc.
See details and how to join2025-524969-24-00 · EU 2025-524969-24-00 - 2/3. fázisNot yet taking people in AusztriaA Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination with Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants with First-Line Metastatic Pancreatic Ductal Adenocarcinoma
- Where
- Linz, Salzburg, Vienna
- Életkor
- 18 év and over
- People
- 194 worldwide
- Run by
- AbbVie Deutschland GmbH & Co. KG
See details and how to join2025-522563-15-00 · EU 2025-522563-15-00 - 3. fázisTaking peopleStudy of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Where
- Graz, Linz, Steyr, Vienna
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT07491445 · EU 2025-525088-34-00 - 1/2. fázisTaking peoplePhase 1b/2 Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Pancreatic Cancer (Substudy PDAC)
- Where
- Salzburg, Vienna
- Életkor
- 18 év and over
- People
- 26 worldwide
- Run by
- Merck Healthcare KGaA
See details and how to join2024-517819-74-00 · EU 2024-517819-74-00 - 3. fázisTaking peoplePhase 3 Study of Investigator Choice of Chemotherapy with or without Zoldonrasib as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma
- Where
- Linz, Salzburg, Vienna, Wels, Wiener Neustadt
- Életkor
- 18 év and over
- People
- 281 worldwide
- Run by
- Revolution Medicines Inc.
See details and how to join2025-524928-21-00 · EU 2025-524928-21-00 - 3. fázisTaking peopleA Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)
- Where
- Innsbruck, Linz, Salzburg, Vienna
- Életkor
- 18 év and over
- People
- 239 worldwide
- Run by
- Incyte Corp.
See details and how to join2025-525009-18-00 · EU 2025-525009-18-00 - No phaseTaking peopleAustrian Registry for Evaluation of Treatment Patterns and Outcome in Patients With Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
- Where
- Amstetten, Feldkirch, Graz, Innsbruck, Klagenfurt, Linz, Salzburg, Sankt Pölten, Vienna, Zams
- Életkor
- 18 év and over
- People
- 1500
- Run by
- Medical University of Graz
See details and how to joinNCT05526443 - No phaseNot yet taking people in AusztriaDigitally Supported Prehabilitation Before Major Visceral Cancer Surgery
- Where
- Saint Veit Im Pongau, Salzburg
- Életkor
- 18 év and over
- People
- 30
- Run by
- Ludwig Boltzmann Institute for Digital Health and Prevention
See details and how to joinNCT07658313 - No phaseTaking peoplePreoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic Cancer
- Where
- Wiener Neustadt
- Életkor
- 18 év and over
- People
- 10
- Run by
- EBG MedAustron GmbH
See details and how to joinNCT04894643 - No phaseTaking peopleRadiotherapy for Locally Advanced Pancreatic Carcinomas (Phase II Trial)
- Where
- Wiener Neustadt
- Életkor
- 18 év and over
- People
- 30
- Run by
- EBG MedAustron GmbH
See details and how to joinNCT05191940 - 2/3. fázisTaking peopleStudy of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
- Where
- Feldkirch, Klagenfurt Am Woerthersee, Linz, Salzburg, Steyr, St. Pölten, Vienna, Wels, Wien
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Panbela Therapeutics, Inc.
See details and how to joinNCT05254171 · EU 2024-514714-12-00 - No phaseTaking peopleThe HELPP Score: A Pretreatment Score to Predict Survival in Pancreatic Cancer
- Where
- Vienna
- Életkor
- 18 év to 99 év
- People
- 1500
- Run by
- Medical University of Vienna
See details and how to joinNCT05752812